These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 9924841

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 5-HT2C receptor involvement in the control of persistence in the reinforced spatial alternation animal model of obsessive-compulsive disorder.
    Papakosta VM, Kalogerakou S, Kontis D, Anyfandi E, Theochari E, Boulougouris V, Papadopoulos S, Panagis G, Tsaltas E.
    Behav Brain Res; 2013 Apr 15; 243():176-83. PubMed ID: 23327741
    [Abstract] [Full Text] [Related]

  • 3. 5-HT2A/C receptors do not mediate the attenuation of compulsive checking by mCPP in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD).
    Tucci MC, Dvorkin-Gheva A, Johnson E, Wong M, Szechtman H.
    Behav Brain Res; 2015 Feb 15; 279():211-7. PubMed ID: 25449840
    [Abstract] [Full Text] [Related]

  • 4. Neurobiology of obsessive compulsive disorder: a possible role for serotonin.
    Winslow JT, Insel TR.
    J Clin Psychiatry; 1990 Aug 15; 51 Suppl():27-31; discussion 55-8. PubMed ID: 2199432
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serotonin and hallucinogens.
    Aghajanian GK, Marek GJ.
    Neuropsychopharmacology; 1999 Aug 15; 21(2 Suppl):16S-23S. PubMed ID: 10432484
    [Abstract] [Full Text] [Related]

  • 13. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
    Murphy DL, Pigott TA.
    J Clin Psychiatry; 1990 Apr 15; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
    [Abstract] [Full Text] [Related]

  • 14. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
    Cussac D, Boutet-Robinet E, Ailhaud MC, Newman-Tancredi A, Martel JC, Danty N, Rauly-Lestienne I.
    Eur J Pharmacol; 2008 Oct 10; 594(1-3):32-8. PubMed ID: 18703043
    [Abstract] [Full Text] [Related]

  • 15. The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.
    Canal CE, Murnane KS.
    J Psychopharmacol; 2017 Jan 10; 31(1):127-143. PubMed ID: 27903793
    [Abstract] [Full Text] [Related]

  • 16. Hallucinogens.
    Nichols DE.
    Pharmacol Ther; 2004 Feb 10; 101(2):131-81. PubMed ID: 14761703
    [Abstract] [Full Text] [Related]

  • 17. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.
    Adams KH, Hansen ES, Pinborg LH, Hasselbalch SG, Svarer C, Holm S, Bolwig TG, Knudsen GM.
    Int J Neuropsychopharmacol; 2005 Sep 10; 8(3):391-401. PubMed ID: 15801987
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.